Indian generic drugmaker Ranbaxy has struggled since its acquisition by Japan’s Daiichi Sanyko. Will the firm fare any better following its purchase by India’s Sun Pharmaceutical Industries?

ranbaxy-pill
india
vuclip (3)
india (1)
indian-workers2
airplane-money
Satya-Nadella
braille-3 (1)
SPONSORED CONTENT

Private Equity Expects Better Times in 2014

An EY/EIU survey shows that stronger global economic growth and expectations for more M&A deals in 2014 will likely spur more private equity activity.
SPONSORED CONTENT

Navigating the White-water World of New Product Development

Developing new products today involves a chain of daunting new challenges.